Keros Therapeutics, Inc.

NASDAQ:KROS

16.42 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -152.992-104.679-58.744-45.361-12.336-1.335
Depreciation & Amortization 0.8150.6740.3780.2780.2080.153
Deferred Income Tax 000.046000
Stock Based Compensation 28.76318.68211.7224.0970.0590.081
Change In Working Capital -2.6514.308-16.072.275-6.7247.949
Accounts Receivables -0.14318-180.922-0.552-0.37
Inventory -4.50501.042-0.9220.5520
Accounts Payables 1.614-0.4081.4850.0611.312-0.002
Other Working Capital 0.384-3.284-0.5972.214-8.0367.951
Other Non Cash Items 1.5560.9530.521.8172.7950.194
Operating Cash Flow -124.508-70.062-62.148-36.894-15.9987.042
Investing Activities:
Investments In Property Plant And Equipment -2.464-1.241-1.024-0.294-0.271-0.217
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 000000
Investing Cash Flow -2.464-1.241-1.024-0.294-0.271-0.217
Financing Activities:
Debt Repayment 000000
Common Stock Issued 175.825119.57828.171243.2020.01411.463
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 3.1310.7310.37952.8420.01411.463
Financing Cash Flow 178.956120.30928.55296.0440.01411.463
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 51.98449.006-34.622258.856-16.25518.288
Cash At End Of Period 332.359280.375231.369265.9917.13523.39